Pharmaceutical Merger | Courthouse News Service
Saturday, December 2, 2023
Courthouse News Service
Saturday, December 2, 2023 | Back issues
Courthouse News Service Courthouse News Service

Pharmaceutical Merger

WILMINGTON, Del. - Directors are selling Cadence Pharmaceuticals too cheaply through an unfair process to Mallinckrodt, for $14 per share or $1.3 billion, a class action claims in Chancery Court.

Categories / Uncategorized

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.

Loading...